Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313368242> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4313368242 endingPage "100678" @default.
- W4313368242 startingPage "100678" @default.
- W4313368242 abstract "Durvalumab following chemoradiation in unresectable stage III non-small cell lung cancer (NSCLC) has led to improved outcomes. The schedule of administration has been determined by pharmacokinetic studies. This study evaluates real-world efficacy and safety outcomes of extended dosing (ED) vs. standard dosing (SD) of durvalumab.Stage III NSCLC patients treated at the Cancer center of Southeastern Ontario with consolidative durvalumab from March 2017-December 2020 were included. Patient characteristics and outcomes were evaluated through retrospective review. Comparisons were made using chi-square and t-tests. Kaplan-Meier curves were used to analyze overall survival (OS).A total of 35 patients were included; 15 (43%) switched to ED. Distant recurrence rates were higher in the ED group (53% vs. 20%, p = 0.07), with no differences in the sites of disease recurrence. A similar proportion of patients were alive in the ED vs. SD group (93% vs. 80%, p = 0.3), with no significant difference in OS. There were less grade 3 or greater immune-related adverse events in the ED group (0% vs. 20%). Treatment discontinuation occurred in 47% vs. 50% in the ED vs. SD groups, respectively, owing to toxicity in 20% of patients in the ED group vs. 40% in the SD group.Extended dosing has similar efficacy and toxicity to standard dosing; however, there was a higher rate of toxicity necessitating discontinuation in the SD group, which may have impacted the clinical decision-making to switch to ED. Our data is limited by a small sample size and should be further validated in larger cohorts." @default.
- W4313368242 created "2023-01-06" @default.
- W4313368242 creator A5001246223 @default.
- W4313368242 creator A5001712658 @default.
- W4313368242 creator A5033573431 @default.
- W4313368242 creator A5056009334 @default.
- W4313368242 creator A5074059705 @default.
- W4313368242 date "2023-01-01" @default.
- W4313368242 modified "2023-10-11" @default.
- W4313368242 title "A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic" @default.
- W4313368242 cites W2753065806 @default.
- W4313368242 cites W2775344839 @default.
- W4313368242 cites W2893824814 @default.
- W4313368242 cites W2977392388 @default.
- W4313368242 cites W3006355661 @default.
- W4313368242 cites W3012696018 @default.
- W4313368242 cites W3034965161 @default.
- W4313368242 cites W3170972079 @default.
- W4313368242 cites W4200334756 @default.
- W4313368242 cites W4221017780 @default.
- W4313368242 cites W4226175083 @default.
- W4313368242 doi "https://doi.org/10.1016/j.ctarc.2022.100678" @default.
- W4313368242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36608489" @default.
- W4313368242 hasPublicationYear "2023" @default.
- W4313368242 type Work @default.
- W4313368242 citedByCount "1" @default.
- W4313368242 countsByYear W43133682422023 @default.
- W4313368242 crossrefType "journal-article" @default.
- W4313368242 hasAuthorship W4313368242A5001246223 @default.
- W4313368242 hasAuthorship W4313368242A5001712658 @default.
- W4313368242 hasAuthorship W4313368242A5033573431 @default.
- W4313368242 hasAuthorship W4313368242A5056009334 @default.
- W4313368242 hasAuthorship W4313368242A5074059705 @default.
- W4313368242 hasBestOaLocation W43133682421 @default.
- W4313368242 hasConcept C121608353 @default.
- W4313368242 hasConcept C126322002 @default.
- W4313368242 hasConcept C141071460 @default.
- W4313368242 hasConcept C143998085 @default.
- W4313368242 hasConcept C146357865 @default.
- W4313368242 hasConcept C151730666 @default.
- W4313368242 hasConcept C167135981 @default.
- W4313368242 hasConcept C197934379 @default.
- W4313368242 hasConcept C207103383 @default.
- W4313368242 hasConcept C2776256026 @default.
- W4313368242 hasConcept C2777288759 @default.
- W4313368242 hasConcept C2777701055 @default.
- W4313368242 hasConcept C2777742743 @default.
- W4313368242 hasConcept C2778715236 @default.
- W4313368242 hasConcept C2780030458 @default.
- W4313368242 hasConcept C29730261 @default.
- W4313368242 hasConcept C44249647 @default.
- W4313368242 hasConcept C71924100 @default.
- W4313368242 hasConcept C86803240 @default.
- W4313368242 hasConceptScore W4313368242C121608353 @default.
- W4313368242 hasConceptScore W4313368242C126322002 @default.
- W4313368242 hasConceptScore W4313368242C141071460 @default.
- W4313368242 hasConceptScore W4313368242C143998085 @default.
- W4313368242 hasConceptScore W4313368242C146357865 @default.
- W4313368242 hasConceptScore W4313368242C151730666 @default.
- W4313368242 hasConceptScore W4313368242C167135981 @default.
- W4313368242 hasConceptScore W4313368242C197934379 @default.
- W4313368242 hasConceptScore W4313368242C207103383 @default.
- W4313368242 hasConceptScore W4313368242C2776256026 @default.
- W4313368242 hasConceptScore W4313368242C2777288759 @default.
- W4313368242 hasConceptScore W4313368242C2777701055 @default.
- W4313368242 hasConceptScore W4313368242C2777742743 @default.
- W4313368242 hasConceptScore W4313368242C2778715236 @default.
- W4313368242 hasConceptScore W4313368242C2780030458 @default.
- W4313368242 hasConceptScore W4313368242C29730261 @default.
- W4313368242 hasConceptScore W4313368242C44249647 @default.
- W4313368242 hasConceptScore W4313368242C71924100 @default.
- W4313368242 hasConceptScore W4313368242C86803240 @default.
- W4313368242 hasLocation W43133682421 @default.
- W4313368242 hasLocation W43133682422 @default.
- W4313368242 hasLocation W43133682423 @default.
- W4313368242 hasOpenAccess W4313368242 @default.
- W4313368242 hasPrimaryLocation W43133682421 @default.
- W4313368242 hasRelatedWork W2003938723 @default.
- W4313368242 hasRelatedWork W2047967234 @default.
- W4313368242 hasRelatedWork W2138660411 @default.
- W4313368242 hasRelatedWork W2340130805 @default.
- W4313368242 hasRelatedWork W2439875401 @default.
- W4313368242 hasRelatedWork W2466043692 @default.
- W4313368242 hasRelatedWork W3169762113 @default.
- W4313368242 hasRelatedWork W4206153238 @default.
- W4313368242 hasRelatedWork W4318478878 @default.
- W4313368242 hasRelatedWork W4386083912 @default.
- W4313368242 hasVolume "34" @default.
- W4313368242 isParatext "false" @default.
- W4313368242 isRetracted "false" @default.
- W4313368242 workType "article" @default.